BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23333070)

  • 1. Synthesis and SAR of ⁹⁹mTc/Re-labeled small molecule prostate specific membrane antigen inhibitors with novel polar chelates.
    Lu G; Maresca KP; Hillier SM; Zimmerman CN; Eckelman WC; Joyal JL; Babich JW
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1557-63. PubMed ID: 23333070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen for molecular imaging of prostate cancer.
    Hillier SM; Maresca KP; Lu G; Merkin RD; Marquis JC; Zimmerman CN; Eckelman WC; Joyal JL; Babich JW
    J Nucl Med; 2013 Aug; 54(8):1369-76. PubMed ID: 23733925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and Radiolabeling of Glu-Urea-Lys with
    Hatamabadi D; Joukar S; Shakeri P; Balalaie S; Yazdani A; Khoramjouy M; Mazidi SM; Kobarfard F; Mosayebnia M; Bozorgchami N; Ahmadi M; Ayyoubzadeh SM; Shahhosseini S
    Cancer Biother Radiopharm; 2023 Sep; 38(7):486-496. PubMed ID: 37578479
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel polar single amino acid chelates for technetium-99m tricarbonyl-based radiopharmaceuticals with enhanced renal clearance: application to octreotide.
    Maresca KP; Marquis JC; Hillier SM; Lu G; Femia FJ; Zimmerman CN; Eckelman WC; Joyal JL; Babich JW
    Bioconjug Chem; 2010 Jun; 21(6):1032-42. PubMed ID: 20402463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of chelators on the pharmacokinetics of (99m)Tc-labeled imaging agents for the prostate-specific membrane antigen (PSMA).
    Ray Banerjee S; Pullambhatla M; Foss CA; Falk A; Byun Y; Nimmagadda S; Mease RC; Pomper MG
    J Med Chem; 2013 Aug; 56(15):6108-21. PubMed ID: 23799782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of technetium-99m- and rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA).
    Banerjee SR; Foss CA; Castanares M; Mease RC; Byun Y; Fox JJ; Hilton J; Lupold SE; Kozikowski AP; Pomper MG
    J Med Chem; 2008 Aug; 51(15):4504-17. PubMed ID: 18637669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isothiocyanate-Functionalized Bifunctional Chelates and fac-[M(I)(CO)3](+) (M = Re, (99m)Tc) Complexes for Targeting uPAR in Prostate Cancer.
    Kasten BB; Ma X; Cheng K; Bu L; Slocumb WS; Hayes TR; Trabue S; Cheng Z; Benny PD
    Bioconjug Chem; 2016 Jan; 27(1):130-42. PubMed ID: 26603218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of Re/
    Radford LL; Papagiannopoulou D; Gallazzi F; Berendzen A; Watkinson L; Carmack T; Lewis MR; Jurisson SS; Hennkens HM
    Bioorg Med Chem; 2019 Feb; 27(3):492-501. PubMed ID: 30594453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of (99m)Tc-labeled asymmetric urea derivatives that target prostate-specific membrane antigen for single-photon emission computed tomography imaging.
    Kimura H; Sampei S; Matsuoka D; Harada N; Watanabe H; Arimitsu K; Ono M; Saji H
    Bioorg Med Chem; 2016 May; 24(10):2251-6. PubMed ID: 27073053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NOTA and NODAGA [
    Makris G; Radford LL; Kuchuk M; Gallazzi F; Jurisson SS; Smith CJ; Hennkens HM
    Bioconjug Chem; 2018 Dec; 29(12):4040-4049. PubMed ID: 30412382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and Biological Evaluation of [
    Xiao D; Duan X; Gan Q; Zhang X; Zhang J
    Molecules; 2020 Nov; 25(23):. PubMed ID: 33256058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Versatile synthetic approach to new bifunctional chelating agents tailor made for labeling with the fac-[M(CO)(3)](+) core (M = Tc, (99m)Tc, Re): synthesis, in vitro, and in vivo behavior of the model complex [M(APPA)(CO)(3)] (APPA = [(5-amino-pentyl)-pyridin-2-yl-methyl-amino]-acetic acid).
    Stichelberger A; Waibel R; Dumas C; Schubiger PA; Schibli R
    Nucl Med Biol; 2003 Jul; 30(5):465-70. PubMed ID: 12831983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Pharmacological Evaluation of New Bone-Targeted (99m)Tc-Radiolabeled Bisphosphonates.
    Makris G; Tseligka ED; Pirmettis I; Papadopoulos MS; Vizirianakis IS; Papagiannopoulou D
    Mol Pharm; 2016 Jul; 13(7):2301-17. PubMed ID: 27170456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, radiolabeling and biological evaluation of new urea-based peptides targeting prostate specific membrane antigen.
    Mosayebnia M; Hajimahdi Z; Beiki D; Rezaeianpour M; Hajiramezanali M; Geramifar P; Sabzevari O; Amini M; Hatamabadi D; Shahhosseini S
    Bioorg Chem; 2020 Jun; 99():103743. PubMed ID: 32217372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and bioevaluation of the cyclopentadienyl tricarbonyl technetium-99m 2-nitroimidazole derivatives for tumor hypoxia imaging.
    Su H; Chu T
    Bioorg Med Chem Lett; 2022 Mar; 60():128583. PubMed ID: 35085720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two is better than one: difunctional high-affinity PSMA probes based on a [CpM(CO)
    Frei A; Fischer E; Childs BC; Holland JP; Alberto R
    Dalton Trans; 2019 Oct; 48(39):14600-14605. PubMed ID: 31549121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ⁶⁴Cu-labeled inhibitors of prostate-specific membrane antigen for PET imaging of prostate cancer.
    Banerjee SR; Pullambhatla M; Foss CA; Nimmagadda S; Ferdani R; Anderson CJ; Mease RC; Pomper MG
    J Med Chem; 2014 Mar; 57(6):2657-69. PubMed ID: 24533799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation, 99mTc-labeling and biodistribution studies of a PNA oligomer containing a new ligand derivative of 2,2'-dipicolylamine.
    Gasser G; Jäger K; Zenker M; Bergmann R; Steinbach J; Stephan H; Metzler-Nolte N
    J Inorg Biochem; 2010 Nov; 104(11):1133-40. PubMed ID: 20674031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and pre-clinical evaluation of a new class of high-affinity
    Kelly J; Amor-Coarasa A; Nikolopoulou A; Kim D; Williams C; Ponnala S; Babich JW
    Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):647-661. PubMed ID: 27847991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [(99m)Tc]Demomedin C, a radioligand based on human gastrin releasing peptide(18-27): synthesis and preclinical evaluation in gastrin releasing peptide receptor-expressing models.
    Nock BA; Cescato R; Ketani E; Waser B; Reubi JC; Maina T
    J Med Chem; 2012 Oct; 55(19):8364-74. PubMed ID: 22966957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.